Media Coverage
2023
22/11/2023
The Perth health-tech company batting well above its average – 6PR Perth Radio, Money News
22/11/2023
Proteomics on a game-changing path to address kidney disease – AusBiz
20/10/2023
Chronic kidney disease with Dr Richard Lipscombe – Channel 9 News Perth 5pm bulletin
09/10/2023
As kidney disease reaches critical levels, doctors urge responsibility – 6PR Perth Radio
29/09/2023
ASX Health Stocks: Proteomics soars 13pc after US sets price for PromarkerD – The Daily Telegraph
28/09/2023
Proteomics International Laboratories Ltd PromarkerD US Reimbursement Price & Aus Regulatory Decision – MarketScreener
27/09/2023
Proteomics develops new blood test for esophageal cancer – BioWorld
14/09/2023
Early diagnosis a step closer for those at risk of oesophageal cancer – BiotechDispatch
14/09/2023
Early detection for oesophageal cancer – Medical Forum
14/09/2023
Early Oesophageal Cancer Diagnosis Now Closer for At-Risk – Mirage News
10/09/2023
Proteomics International Laboratories Ltd (ASX:PIQ) New Oesophageal Cancer Test Presented At Global Conference – Menafn
08/09/2023
Proteomics International (ASX:PIQ) to present new oesophageal cancer test at global conference – The Market Herald
08/09/2023
Proteomics blood test primed for cancer fight – The West Australian
04/09/2023
Proteomics International Laboratories Ltd OxiDx Platform Technology Secures Patent in Japan – The West Australian
15/06/2023
Intervention needed to stop kidney disease overwhelming NHS, Kidney Research UK says – Evening Standard
Newsroom
News Archive
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
1
2
3
4
5
6
7
8
9
…
12
Subscribe
Title
Name
*
Position
Company/Organisation
*
Phone
Email
*
Terms & Conditions
*
I accept the terms and conditions
Email
This field is for validation purposes and should be left unchanged.
Company
About Us
Mission Statement
Senior Staff
Board of Directors
Clinical Advisory Board
Customer Testimonials
Quality Control
Careers
Glossary
PromarkerD
Promarker™ Pipeline
Project Statuses
Biomarker Discovery
Analytical Services
Pharmacokinetic Testing
Biosimilars/Biologics Drug Characterisation
Proteome Mapping
Proteome Quantitation (iTRAQ, TMT, Label-Free)
Targeted Mass Spectrometry (MRM/SRM)
Protein ID by Mass Spectrometry
Post-translational Modifications (PTMs)
Additional Services
Project Consultation
Pricing and Ordering
Downloads
Terms and Conditions
FAQs
Newsroom
Media Releases
Media Coverage
Newsletters
Publications
Events and Presentations
Investors
ASX Announcements
Share Price and Analyst Coverage
Library
Reports
Corporate Governance
Shareholder Information
Annual General Meeting
Contact
Sample Delivery
Technical
Business Development
Agents